RNA Analysis Transcriptomics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Consumables, Instruments, Software, Services), By Technology (Microarrays, qPCR, Sequencing Technology), By Application (Drug Discovery, Diagnostics and Disease Profiling, Others), and Region Forecast 2019-2030           

RNA Analysis Transcriptomics Market size was valued at US$ 8,648.3 Million in 2023 and is poised to grow at a significant CAGR of 16.9% from 2024-2030. Transcriptomics is the study of the RNA transcripts set produced by the organisms genome. Transcriptome analysis allows researchers to learn about the sequence and function of DNA. The increased demand for specific genes, quantification of multiplexed RNA, various assay technologies, increased need for genetic testing and personalized medicine and rise in genetic variation and genetic mutation incidences drive the market demand.

The Consumables segment is anticipated to grow at a significant CAGR over the forecast years owing to expanding pharmaceutical R&D activity, as well as increased government financing for life sciences research. For example, in March 2022, the Government of Canada allocated $13.8 million in government funding to deploy genomics through ten downstream processing R&D initiatives. The growing emphasis on biomarker development and toxicogenomic, as well as the growing interest in outsourcing services, are likely to provide substantial potential possibilities for companies in the global RNA analysis/transcriptomics market.

RNA Analysis Transcriptomics market Key Developments

In June 2022, Fluent BioSciences a private funded biotechnology company launched the PIPseqTM technology for single-cell RNA analysis in laboratories. In February 2022, QIAGEN leading global provider of Sample partnered with Singular Genomics Systems Inc. to get their QIAseq kits validated.